login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
NERVGEN PHARMA CORP (NGEN.CA) Stock News
TSX-V:NGEN - TSX Venture Exchange -
CA64082X2032
-
Common Stock
- Currency: CAD
3.55
-0.16 (-4.31%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NGEN.CA Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: NervGen Pharma Corp.
NervGen Pharma Reports Positive Topline Data from the Chronic Cohort of its Phase 1b/2a Clinical Trial Evaluating NVG-291 in Spinal Cord Injury
5 months ago - By: Virtual Investor Conferences
- Mentions:
CGTX
AVCN.CA
COCP
FBLG
...
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
5 months ago - By: Virtual Investor Conferences
- Mentions:
CGTX
AVCN.CA
COCP
FBLG
...
Life Sciences Investor Forum Agenda Announced for March 13th
2 years ago - By: Virtual Investor Conferences
- Mentions:
MDNC
RSLS
BABY.CA
KPRX
Life Science Investor Forum Agenda Announced for June 22nd
3 years ago - By: NervGen Pharma Corp.
- Mentions:
TSX
NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Repair From a Stroke 7 Days After Onset in Landmark Preclinical Study by University of Cincinnati and Case Western Reserve University
4 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
IIROC Trading Resumption - NGEN
4 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
IIROC Trading Halt - NGEN
Please enable JavaScript to continue using this application.